These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8502814)

  • 1. High-dose adjuvant chemotherapy for high-risk breast cancer.
    Abeloff MD
    Recent Results Cancer Res; 1993; 127():177-83. PubMed ID: 8502814
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolated/primary CNS relapse in women in remission after ABMT for metastatic breast cancer.
    Ellis ED; Williams SF
    Bone Marrow Transplant; 1992 Feb; 9(2):147-9. PubMed ID: 1315184
    [No Abstract]   [Full Text] [Related]  

  • 4. Issues in the chemotherapy of breast cancer.
    de Graaf H; Willemse PH; de Vries EG; Mulder NH
    Neth J Med; 1998 Sep; 53(3):97-108. PubMed ID: 9803140
    [No Abstract]   [Full Text] [Related]  

  • 5. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
    Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
    Lancet; 2000 Oct; 356(9239):1384-91. PubMed ID: 11052580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 7. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
    Ragaz J; Spinelli JJ
    Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant chemotherapy in breast carcinoma].
    Engelsman E
    Ned Tijdschr Geneeskd; 1984 Sep; 128(37):1767-71. PubMed ID: 6483049
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal therapy for stage-II breast cancer.
    Baum M
    Lancet; 1977 Sep; 2(8037):564. PubMed ID: 95775
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancers of the breast. First line chemotherapy for cancers of the breast].
    Mauriac L
    Bull Cancer Radiother; 1995; 82(2):158-67. PubMed ID: 7546886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant therapy for breast cancer.
    Budman DR; Citron ML
    Clin Obstet Gynecol; 1994 Dec; 37(4):978-87. PubMed ID: 7842566
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-intense adjuvant treatment of high-risk breast cancer.
    Bonadonna G; Valagussa P
    J Natl Cancer Inst; 1990 Apr; 82(7):542-3. PubMed ID: 2313728
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer.
    Marks LB; Rosner GL; Prosnitz LR; Ross M; Vredenburgh JJ; Peters WP
    Cancer; 1994 Dec; 74(11):2964-71. PubMed ID: 7954260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
    Sdrobolini A
    Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows].
    Lelli G
    Recenti Prog Med; 2000 Dec; 91(12):647-9. PubMed ID: 11194485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adjuvant therapy also in node-negative breast cancer?].
    Barth JA
    Zentralbl Gynakol; 1990; 112(2):57-9. PubMed ID: 2316296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.